Skip to main content
Trials logoLink to Trials
. 2013 Nov 1;14:365. doi: 10.1186/1745-6215-14-365

Vancouver At Home: pragmatic randomized trials investigating Housing First for homeless and mentally ill adults

Julian M Somers 1,, Michelle L Patterson 1, Akm Moniruzzaman 1, Lauren Currie 1, Stefanie N Rezansoff 1, Anita Palepu 2, Karen Fryer 1
PMCID: PMC4228396  PMID: 24176253

Abstract

Background

Individuals with mental illnesses are overrepresented among the homeless. Housing First (HF) has been shown to promote positive outcomes in this population. However, key questions remain unresolved, including: how to match support services to client needs, the benefits of housing in scattered sites versus single congregate building, and the effectiveness of HF with individuals actively using substances. The present study aimed to recruit two samples of homeless mentally ill participants who differed in the complexity of their needs. Study details, including recruitment, randomization, and follow-up, are presented.

Methods

Eligibility was based on homeless status and current mental disorder. Participants were classified as either moderate needs (MN) or high needs (HN). Those with MN were randomized to HF with Intensive Case Management (HF-ICM) or usual care. Those with HN were randomized to HF with Assertive Community Treatment (HF-ACT), congregate housing with support, or usual care. Participants were interviewed every 3 months for 2 years. Separate consent was sought to access administrative data.

Results

Participants met eligibility for either MN (n = 200) or HN (n = 297) and were randomized accordingly. Both samples were primarily male and white. Compared to participants designated MN, HN participants had higher rates of hospitalization for psychiatric reasons prior to randomization, were younger at the time of recruitment, younger when first homeless, more likely to meet criteria for substance dependence, and less likely to have completed high school. Across all study arms, between 92% and 100% of participants were followed over 24 months post-randomization. Minimal significant differences were found between study arms following randomization. 438 participants (88%) provided consent to access administrative data.

Conclusion

The study successfully recruited participants meeting criteria for homelessness and current mental disorder. Both MN and HN groups had high rates of substance dependence, suicidality, and physical illness. Randomization resulted in no meaningful detectable differences between study arms.

Trial registration

Current Controlled Trials: ISRCTN57595077 (Vancouver at Home study: Housing First plus Assertive Community Treatment versus congregate housing plus supports versus treatment as usual) and ISRCTN66721740 (Vancouver At Home study: Housing First plus Intensive Case Management versus treatment as usual).

Keywords: Housing First, Homelessness, Mental illness, Concurrent disorders

Background

Individuals who are homeless and mentally ill are heterogeneous in their health and social challenges. Effective models of service must be responsive to individual needs, which may vary across time and space, and are constrained by pragmatic factors, including local standards of care, housing availability, and funding. The Vancouver At Home (VAH) project has implemented two randomized controlled trials (RCTs) involving homeless mentally ill adults in Vancouver, BC, Canada. VAH is collaborating with similar projects in four other Canadian cities [1]. Each collaborating center has incorporated a common methodology, with pragmatic adaptations in each site. Site-specific adaptations were influenced by the characteristics of each local population (for example, ethno-racial services in Toronto, ON, Aboriginal focus in Winnipeg, MB), as well as the structural features of each locale (for example, rural service models in Moncton, NB, congregate housing in Vancouver, BC). The purpose of the present article is to describe the unique features of VAH, including measures, interventions, and sample characteristics in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement for the reporting of pragmatic trials.

We briefly describe the physical setting of Vancouver, the local population who are both homeless and mentally ill, and the Housing First (HF) program. These factors influenced both the design and implementation of VAH with the goal of maximizing the effectiveness and relevance of the project.

For decades, the city of Vancouver has struggled to meet the needs of a visibly homeless and inadequately sheltered population in a central downtown neighborhood. The same neighborhood has been afflicted by high crime rates, an open market for illicit drugs, infectious diseases, and premature mortality [2]. For many years, the most affordable housing in the neighborhood has consisted of single room occupancy (SRO) hotels, many of which earned a reputation for hazards ranging from bed bugs to criminal predation [3,4]. Individuals with mental illness are prominent among the homeless, particularly following 'deinstitutionalization’, whereby regional psychiatric facilities were downsized as promises to implement community-based support, such as Assertive Community Treatment (ACT), were unfulfilled. A diverse array of services emerged over time to support individuals in the neighborhood, including outreach services, meal programs, shelters, drug-related services (for example, needle exchange, supervised injection site [5]), and varied forms of supported housing.

The City of Vancouver has implemented a plan with the goal to 'end street homelessness’ by 2015. A key element of the plan involves the construction of apartment buildings to provide housing and support for the homeless. However, key questions remain unresolved regarding the appropriate mix of occupants in these buildings and the type of support that would be required to promote stable occupancy and recovery among individuals who are leaving homelessness and who have differing needs.

Prior to VAH, no study had systematically examined the health and housing status of individuals who were homeless and mentally ill in Vancouver. A considerable amount of anecdotal and descriptive information was available from sources, such as shelter operators, street outreach clinicians, police, and from research involving samples that included homeless individuals (for example, patients with HIV/AIDS, survival sex workers [4,6,7]). The available evidence suggests that the local population of homeless mentally ill individuals struggles with complex social and medical problems, including infectious diseases, frequent polysubstance use, cognitive impairment, trauma, victimization, and poor food security [4,8]. It had also been reported that homeless individuals were using emergency and hospital services due to inadequate community care, and were frequently involved with the justice system [7,9]. Based on these considerations, it was anticipated that VAH would extend the HF model to clients with more complex needs than those described in previous trials, including participants with concurrent substance use disorders.

A growing literature supports the effectiveness of the HF model for individuals who are both homeless and mentally ill. HF emphasizes the value of client choice and has been shown to promote residential stability [10,11], community integration [12], and high levels of client satisfaction [13]. Originating from the Pathways model in New York City, NY, USA, HF involves building a portfolio of rental accommodations (typically apartments) scattered throughout different neighborhoods, thereby providing clients with meaningful choices concerning the location and setting of their residence [14]. Clients are then supported in their homes by either an HF with Assertive Community Treatment (HF-ACT) team or HF with Intensive Case Management (HF-ICM), depending on their level of needs. ACT was originally created to constitute a 'hospital without walls’ enabling individuals who might otherwise have been admitted to psychiatric facilities to instead pursue recovery in community settings [15]. ACT teams are available 24/7, and include varied expertise across multiple disciplines. The effectiveness of ACT has been well established among individuals who reflect the original target population (that is, individuals with psychotic disorders or bipolar disorder), including specific outcomes, such as reductions in hospital admissions and criminal justice involvement [16,17]. However, the effectiveness of HF-ACT is less well known among sub-populations who also have cognitive impairments, complex addictions, or multiple physical and mental illnesses.

The majority of studies examining HF have followed participants for up to 24 months (for example, Gulcur [11], Tsemberis and Eisenberg [14]). Longer-term research involving diverse residential interventions for homeless individuals in New York City found that housing stability decreased after 1, 2, and 5 years (75%, 64%, and 50%, respectively) [18]. Several studies have reported that substance use disorders are predictive of lower housing stability regardless of residence type [19,20]. Preliminary evidence suggests that congregate HF (that is, a single supported building) may achieve housing stability and cost savings among homeless men who are alcohol dependent [21]. However, it is not known whether these results would be replicated among mentally ill users of illicit (or multiple) substances and who receive scattered site HF.

Compared to ACT, the effectiveness of ICM has received less empirical attention in the context of supported housing for individuals with mental illness, and its definition varies widely [22]. Unlike HF-ACT, which provides a broad range of specialized services directly to clients, HF-ICM operates as a liaison connecting clients with community services based on their expressed needs. The success of HF-ICM is therefore a function of the complexity of client needs, as well as the availability and appropriateness of relevant community resources. HF-ICM may be appropriate for clients with less severe mental illness or as a step-down from HF-ACT following successful stabilization. For example, as part of a multicenter trial, the Boston McKinney study [22] randomized homeless adults with mental illness to independent apartments or small group homes, both of which received 'comprehensive case management’. Findings indicated that housing availability, regardless of type, was the primary predictor of subsequent ability to avoid homelessness, while enhanced services reduced the risk of homelessness if housing was also available. Substance abuse was the strongest single predictor of days homeless [22,23].

The primary objectives of this article are:

1. To report study details including measures and interventions that are unique to VAH.

2. To present details of recruitment and follow-up rates for participants in VAH including primary data collection and administrative data.

3. To present baseline characteristics and examine potential non-equivalence between randomization arms in each trial.

4. To examine differences in the complexity of needs between participants in the two trials.

Methods

Community engagement

Development of the research protocol was preceded by several community meetings and by six focus groups with individuals who had experienced homelessness and mental illness in the Vancouver area. In total, 58 individuals were convened with the assistance of community agencies, and met privately with an experienced academic facilitator who took notes and prepared reports of proceedings. Focus group participants were asked to advise on procedures to enhance the relevance of the research, to minimize risks and maximize benefits to participants, and ways to incorporate the expertise of individuals with direct experiences of homelessness in the research project. Narrative feedback from respondents (for example, amounts of honoraria, the need to include individuals who had experienced homelessness as members of service teams and on the research team) were included in the grant application and later implemented as part of the project. Service provider representatives were consulted extensively during the design of the research and were invited to respond to a request for proposals to implement the major services that comprised the interventions tested in the study: HF-ACT, HF-ICM, scattered site housing portfolio management, and congregate housing with support.

Recruitment

Participants were recruited through service providers and agencies serving individuals who are homeless and mentally ill in Vancouver, including shelters, drop-in centers, street outreach workers, hospitals, police, and courts. An effort was made to locate individuals throughout Vancouver, while recognizing that the majority of visible homelessness and related services were concentrated in one area.

Eligibility and level of needs

Eligible participants were Canadian citizens at least 19 years of age who met criteria for homelessness or precarious housing and current mental disorder status. Informed consent required that individuals were made aware that randomization would involve assignment to either a pre-specified intervention that included housing or to usual care consisting of existing services and support. Participants and interviewers were therefore not blinded to the results of randomization.

Operational definitions

Homelessness was defined as having no fixed place to sleep or live for more than 7 nights and little likelihood of obtaining accommodation in the coming month. Precarious housing was defined as currently residing in marginal accommodation, such as a SRO hotel, and having two or more episodes of homelessness (as defined above) during the past 12 months. These were minimal criteria, and participants with more long-standing homelessness were eligible for inclusion. Current mental illness was assessed using the Mini-International Neuropsychiatric Interview (MINI) [24] for the following: major depressive episode, manic or hypomanic episode, post-traumatic stress disorder, mood disorder with psychotic features, and psychotic disorder. Where possible, mental disorder status was corroborated by physician diagnosis. Participants were categorized as moderate needs (MN) or high needs (HN). Inclusion in the HN study was based on Multnomah Community Ability Scale (MCAS) [25] score of 62 or lower and current bipolar or psychotic disorder, as well as one of the following: legal involvement in the past year, substance dependence in the past month, and two or more hospitalizations for mental illness in any one of the past 5 years. All other eligible participants were included in the MN study.

Retention strategies

A team of full-time and part-time field interviewers was recruited to follow participants at 3-month intervals. Interviewers received in-depth training and supervision in the administration of measures, and scales and items were pre-tested with a sample of participants. Interviews were considered 'on time’ if they occurred within 2 weeks of the designated anniversary date. Participants were paid C$35 for the baseline interview and approximately C$30 for each subsequent interview. Scales were administered verbally and responses entered immediately on laptop computers. Major interviews conducted at 6-month intervals required between 90 to 180 minutes to complete in most cases. A field research office was open daily throughout the study period, and participants were encouraged to drop-in regardless of their interview schedule. Interviewers obtained periodic updates regarding participants’ routines and typical whereabouts, and collateral contact information was sought in order to aid with relocation. Interviews were conducted in various locations based on randomization arm and participant preference, including participants’ homes, field research office, and public settings, such as restaurants, parks, and drop-in centers.

Randomization

After establishing eligibility for either the MN or HN study, a computerized adaptive randomization procedure was followed to assign participants to study arms. Interviewers used laptop computers with secure live connections to upload data and receive randomization results prior to notifying participants of the outcome. Sample sizes of 100 participants in each study arm were derived based on effect size estimates of 0.5 for the major outcome variables, power of 0.80 (β = 0.20), an attrition rate of 40%, and significance levels of 0.05 (two-tailed). Additional details of sample size estimates are reported separately [1]. Based on their first 30 clients, the HF-ACT team determined that they would be able to support no more than 90 clients, and the upper limit of this arm was revised accordingly.

Measures

VAH researchers collaborated with investigators in four other study centers and the study funder to develop a common battery of repeated measures. In addition, a number of site-specific measures were implemented at different intervals during the study (Table 1). Both shared and site-specific measures were selected based on the review of existing literature and toward addressing major gaps in knowledge. Measures were administered at single time points if their results were historical or highly stable (for example, adverse childhood events). Repeated measures (for example, quality of life, community integration) were hypothesized to be subject to variation over time based on the randomization arm, with superior outcomes in experimental conditions compared to treatment as usual (TAU). We similarly hypothesize that the models of service introduced through the study would cause superior outcomes when compared to TAU on measures of hospitalization, emergency department visits, and justice system involvement.

Table 1.

Vancouver At Home (VAH) questionnaire details

Acronym Full name Timeline Key domain/topics References
ACC
Health service access items
BL, 6, 12, 18, 24
Use of community services: regular family physician or health clinic use, and perceived unmet healthcare needs.
[26,27]
ACE
Adverse Childhood Experiences
18
Psychiatric and physical health, traumatic early life events.
[28]
CI
Cognitive impairment
6, 24
Level of independent community functioning, psychiatric and physical health: Hopkins Verbal Learning Test, Trail Making Test, and Digit Symbol Test.
[29-32]
CIS
Community integration scale
BL, 6, 12, 18, 24
Level of independent community functioning, quality of life: community participation and sense of belonging.
[33-35]
CSI
Colorado Symptom Index (modified)
BL, 6, 12, 18, 24
Psychiatric and physical health: frequency of past month’s psychiatric symptoms.
[36-39]
CTS1
Conflict tactics scale
24
Level of independent community functioning: frequency and severity of interpersonal conflict.
[40]
CMC
Comorbid conditions list
BL
Psychiatric and physical health: presence of chronic and infectious diseases.
[41]
C-SSS
Core service satisfaction scale
24
Quality of life, use of community services: participant satisfaction with services provided by Vancouver At Home (VAH) intervention teams.
[42,43]
DSHH
Demographics, housing, vocational, and service use history
BL
Housing status, use of community services: sociodemographic details, lifetime duration of homelessness, long-term health, social and justice service use, and vocational history.
[44]
EQ-5D
EuroQol 5D
BL, 6, 12, 18, 24
Psychiatric and physical health, health-related quality of life.
[45-47]
FS
Social support items and food security
BL, 6, 12, 18, 24
Use of community services, psychiatric and physical health: type, quality, availability and source of food, and recent history of food insecurity.
[48,49]
GAIN-SPS
Global Appraisal of Individual Needs, Substance Problem Scale
BL, 6, 12, 18, 24
Substance-related problems.
[50,51]
HSJSU
Health, social, and justice service use inventory
BL, 6, 12, 18, 24
Use of community services, psychiatric and physical health: nature and frequency of health, social, and justice system services.
[42,52-57]
III
Interviewer impression items
BL, 3, 6, 9, 12, 15, 18, 21, 24
Level of independent community functioning: interviewer assessment of validity and reliability of self-report data.
 
LR
Landlord relations
18
Housing status: specific to landlord relationship.
 
PHQL
Perceived housing quality
6, 12, 18, 24
Housing status: subjective housing quality assessed by participants.
[58,59]
MCAS
Multnomah Community Ability Scale
BL, 6, 12, 18, 24
Level of independent community functioning: interviewer assessed level of functioning across range of domains.
[25,60]
MINI
Mini-International Neuropsychiatric Interview
BL
Psychiatric and physical health: current major Axis I disorders and suicidality.
[24,61-63]
MH
Mobility history
21
Housing status: geographic mobility.
 
MoCA1
Montreal Cognitive Assessment
21
Level of independent community functioning: assessment of cognitive domains indicated for the screening of neurological deficits.
[64]
OHQS
Observer-rated Housing Quality Scale
24
Housing status: objective ratings of physical characteristics of participant dwellings.
 
PAIN1
Chronic pain screener
21
Quality of life, psychiatric and physical health.
 
QoLI-20
Quality of Life Index, 20-item
BL, 6, 12, 18, 24
Quality of life, psychiatric and physical health: subjective quality of life across range of domains.
[65-67]
RAS-22
Recovery Assessment Scale, 22-item
BL, 24
Quality of life, psychiatric and physical health.
[68-70]
RTLFB
Residential Time-Line Follow-Back
3, 6, 9, 12, 15, 18, 21, 24
Housing status: detailed chronology of housing status, including frequency of moves, type of accommodation, and household composition.
[39,71]
SCNR
Eligibility screening instrument
BL
Housing status, psychiatric and physical health: determines participation eligibility based on legal adult status (>19 years in British Columbia (BC)), absolute homelessness or precarious housing status, and current mental illness.
[24,61-63]
SF-12
SF-12 Health Survey
BL, 6, 12, 18, 24
Psychiatric and physical health, level of independent community functioning: assessment of the extent of impairment caused by both physical and mental illness.
[45,72,73]
VFC1
Foster care history
12
Quality of life, psychiatric and physical health: details early life involvement in the child welfare system.
 
VMAP1
Maudsley Addiction Profile
BL, 6, 12, 18, 24
Psychiatric and physical health: past month’s substance use, including drug type, mode of administration, frequency of use, and drug-related harms.
[74]
VTLFB
Vocational Time-Line Follow-Back
3, 6, 9, 12, 15, 18, 21, 24
Level of independent community functioning: detailed chronological recent history of paid work and educational or skills training. Quantifies income and income sources.
[75]
WAI-PAR
Working Alliance Inventory, participant
6, 12, 18, 24
Use of community services and quality of life: participant (WAI-PAR) and service provider (WAI-PRO) assessment of working relationship with key service provider. Assessment of perception of client-provider relationship, support, confidence, and trust. [76-80]
WAI-PRO
Working Alliance Inventory, provider 12

1Vancouver site-specific scales. Timeline: BL, baseline; 3, 3-month visit; 6, 6-month visit; 9, 9-month visit; 12, 12-month visit; 15, 15-month visit; 18, 18-month visit; 21, 21-month visit; 24, 24-month visit.

The domains addressed by the cross-site scales are: housing and vocational status, psychiatric and physical health, level of independent community integration and functioning, quality of life, and use of community services. The following questionnaires were administered at baseline and at 6-month intervals: health service access items (ACC) [26,27]; community integration scale (CIS) [33]; Colorado Symptom Index (modified) (CSI) [36]; EuroQol 5D (EQ-5D) [45]; Global Appraisal of Individual Needs, Substance Problem Scale (GAIN-SPS) [50]; SF-12 Health Survey (SF-12) [72]; Quality of Life Index, 20-item (QoLI-20) [65]; social support items and food security (FS); health, social, and justice service use inventory (HSJSU); and MCAS [25]. Two instruments were administered at 3-month intervals, Residential Time-Line Follow-Back (RTLFB) [71] and Vocational Time-Line Follow-Back (VTLFB) [75], to produce a continuous timeline of housing status and vocational status, respectively. The Recovery Assessment Scale, 22-item (RAS-22) [68] was administered at baseline and 24 months, and the Adverse Childhood Experiences (ACE) questionnaire [28] was administered once at 18 months after baseline. A number of other measures were implemented at a single time-point: comorbid conditions list (CMC) [41], landlord relations (LR), Observer-rated Housing Quality Scale (OHQS), mobility history (MH), and core service satisfaction scale (C-SSS) [42,43]; or at other intervals: cognitive impairment (CI) (Hopkins Verbal Learning Test, Trail Making Test, Digit Symbol Test) [29-32], perceived housing quality (PHQL) [58,59], and Working Alliance Inventory (WAI) [76-80]. Semi-structured narrative interviews were scheduled at baseline and 18-month time points with approximately fifty participants (10 from each study arm in the two VAH trials).

Site-specific measures were selected based on study hypotheses and the anticipated characteristics of the Vancouver homeless population. Major areas of hypothesis testing were: addictions, cognitive impairment, and psychiatric severity would negatively influence housing stability; HF would result in superior outcomes when compared to TAU, including reduced use of crisis services and justice system encounters, superior housing stability, and quality of life; and HF would produce superior health outcomes compared to TAU.

The Maudsley Addiction Profile (MAP) [74] is a multidimensional instrument assessing alcohol and drug use and related harms, administered at 6-month intervals. The Montreal Cognitive Assessment (MoCA) [64] assesses several cognitive domains and is indicated for the screening of neurological deficits in younger populations (for example, traumatic brain injury, brain tumors, vascular cognitive impairment). The foster care history (VFC) was administered once at 12 months after baseline. The MoCA, conflict tactics scale [40], and pain scales (assessing acute and chronic pain; Schutz, unpublished) were administered at 21 months only.

Ten participants in each study arm (n = 50) were invited to participate in open-ended, qualitative interviews planned for baseline and 18 months after recruitment. Participants were selected purposively in order to represent differences across gender, ethnicity, duration of homelessness, and degree of functional impairment. Interview questions were organized around the following themes: pathways into and out of homelessness; high, low, and turning points in life; and challenges and enabling factors related to recovery.

In addition, fifty participants were asked to provide consent to undergo physical health examinations involving basic physician assessment and blood analysis (for example, hepatitis B/C, HIV/AIDS). These assessments were included to examine the possibility of undetected illness among members of the study cohorts. Finally, all participants were asked to provide consent for the researchers to send their identifying details to public agencies in order to then receive administrative data regarding their use of health, justice, and social welfare services (separate consent was sought for each category of agency). An inter-agency data sharing protocol was created by a prior project and was used as the basis for the current data extract. The fields of data specified for inclusion were: physician services; hospital services; pharmaceutical services; community mental health and substance use services; vital statistics; justice events, including convictions and sentences; and financial assistance.

Interventions

Participants in both the MN and HN studies were randomized to either an intervention based on the principles of HF or to TAU. In both studies, TAU participants did not receive any housing or support services through the study, but were able to access existing services and support for individuals who are homeless and mentally ill in Vancouver. The resources comprising TAU include shelters, SRO hotels, and community services described earlier. No research has previously examined the responsiveness and effectiveness of these services by following a cohort of homeless individuals prospectively. Coincident with this study, the City of Vancouver and the provincial housing authority were in the process of expanding services for the homeless [81]. The quality and type of housing received by participants in TAU will be carefully documented alongside the receipt of services and support attendant to housing. In addition to TAU, HN participants were randomized to either HF-ACT or Congregate Housing with Support (CONG). MN participants received either TAU or HF-ICM.

Service providers for each intervention were selected through a competitive request for proposals. Applications were reviewed by a panel of senior individuals drawn from homelessness research, management of services, and community granting agencies. The criteria for assessment included the delineation of organizational experience, plans for implementation, and budget. Each selected service provider received specific training in the delivery of HF, and underwent fidelity assessments by external review teams at two points during the study (see below). Services were based on the model defined by Pathways to Housing [82], including expertise that anticipated the needs of local clients (for example, addiction severity), and configured to support participants in both scattered and congregate housing configurations. Participants randomized to HF were transitioned to a case manager within 2 days of study recruitment.

An inventory of apartments was developed in a variety of neighborhoods throughout the city. These apartments were drawn from private market rentals with numerous landlords. In order to promote community integration, a maximum of 20% of the units in any building could be allocated to program participants. Consistent with the principles of HF, participants were provided with a choice of housing units [82]. A housing portfolio manager was responsible for building and maintaining relationships with landlords, including relocating participants to more suitable locations when needed. Participants in the scattered site conditions (HF-ACT and HF-ICM) received support in their homes and were expected to meet with program staff on a weekly basis. The CONG condition was mounted in a single vacant hotel with the capacity to house approximately 100 occupants in independent suites but without full kitchens. The building was located in a mixed residential and commercial neighborhood, adjacent to numerous amenities. The building was equipped with a number of facilities to support residents and to promote the development of a positive community culture, including: central kitchen and meal area, medical examination room and formulary, and recreational areas (yoga, basketball, road hockey, lounge). Tenants were provided with opportunities to engage in part-time work both within the building (for example, meal preparation, laundry) and in the community (for example, providing a graffiti removal service). A reception area and front desk were staffed 24 hours a day. Tenancy in any of the experimental housing conditions was not contingent on compliance with specific therapeutic objectives (for example, addiction treatment). Program staff in each intervention condition participated in a series of training events in person in order to enhance consistency in practices. Subsidies were provided through the study to ensure that participants paid no more than 30% of the total income on rent. Fidelity assessments were conducted by an external team, with representatives from Pathways to Housing, the study funder, and individuals who had experienced homelessness. Assessments were conducted at two time points (12 and 24 months after implementation) using a HF fidelity scale [82], and involved meetings with staff as well as participants in each of the HF interventions. The assessment team provided verbal and written feedback to the staff at each intervention.

VAH outcomes

The primary outcome domains for both trials are: housing stability, health status, quality of life, and service use. Secondary outcome domains are: cost avoidance and cost effectiveness. Primary outcomes will be compared between HF and TAU, including examination of similarities and differences between congregate and scattered site configurations of HF in the HN sample. Previous research has reported greater reductions in homelessness with group housing than with placement in independent apartments [22]. Particular attention will be paid to the role of substance use in relation to primary outcomes. Service use outcomes and economic analyses will be conducted using administrative data sources as specified.

Data collection and analysis plan

Repeated measures (3- and 6-month scales) were collected over 24 months. Based on previous studies and the results reviewed above, approximately 2 years of follow-up was regarded as sufficient to detect changes in the major outcome domains. Fifteen months after commencing recruitment, the cross-site protocol was shortened from 24 to 21 months. Following this change, VAH revised the composition of the 21-month interview in order to provide more complete data for cross-site end point analyses; however, VAH continued to collect data through to 24 months and preserved the original protocol as specified in the trials’ registration. Differences between sites in the protocol change were primarily due to differences in financial resources between study centers. Preserving the original slightly longer follow-up in Vancouver was deemed important owing to the high levels of comorbidity, substance dependence, and chronicity of homelessness within the sample.

Descriptive statistics (such as mean, median, standard deviation, and proportions) were calculated for all quantitative instruments administered at baseline. Comparisons of variables between groups were conducted using parametric tests (t-tests or one-way analysis of variance (ANOVA) for continuous variables) and non-parametric tests (Mann–Whitney or Kruskal–Wallis test for continuous variables; Pearson’s chi-squared or Fisher’s exact tests for categorical variables), as appropriate. All reported P values were two-sided.

Longitudinal analyses of VAH data were planned for 12 and 24 months using several analytic methods, such as hierarchical linear modeling (HLM), generalized estimating equations (GEE), and time-to-event analysis (such as Cox regression and negative binomial regression), as appropriate. All longitudinal analyses are based on intention-to-treat. The major domains of longitudinal analysis examine the overall robustness of interventions to promote health and recovery among groups of participants, and investigate individual characteristics that may predict different responses to interventions. Planned analyses also include examination of service use and cost outcomes using administrative data in combination with interview results. Sensitivity analysis will be conducted to evaluate the effect of missing data using several methods, including mean substitution, multiple imputations, and last observation carried forward.

The results of narrative interviews will be analyzed according to the organizing themes of pathways into and out of homelessness, and high, low, and turning points in life. These thematic analyses are expected to complement results from questionnaires. Post hoc analyses will be informed by qualitative findings, and will also examine the characteristics of individuals who appear to exhibit better (and worse) outcomes regardless of randomization arm. In a related vein, ideographic analyses will be performed to examine whether CONG, HF-ACT, and TAU may be associated with better outcomes for differing subpopulations.

Administrative data will be analyzed to provide long-term (that is, up to 15 years prior to randomization) historical perspectives on trajectories of service use prior to and following homelessness. Administrative data will also be used as key outcome measures (for example, changes in hospitalization) and to validate specific items also collected via self-report (for example, hospitalized in past 6 months).

Data derived through the shared cross-site protocol are owned by the study sponsor. Data that are specific to VAH (unique instruments, administrative data) will be retained at the host institution (Simon Fraser University, Burnaby, BC, Canada). The use and storage of provincial administrative data are governed by Information Sharing Agreements between the Government of British Columbia and Simon Fraser University. The research protocol underwent institutional ethics review and was approved by Simon Fraser University.

Results

Recruitment was carried out between October 2009 and April 2011. Follow-up interviews were completed on a schedule following each individual’s anniversary and were completed by May 2013. Approximately 800 individuals were screened by telephone. Referral sources (n = 40) represented about thirteen different types of services available to homeless adults with mental illness. The majority of potential participants were referred from homeless shelters, drop-in centers, homeless outreach teams, hospitals, community mental health teams, and criminal justice programs. Approximately 100 individuals were excluded via telephone due to clear ineligibility. A further 200 were excluded through the baseline interview procedure due to ineligibility (n = 94), unable to contact for baseline interview (n = 100), declining to participate (n = 3), or incomplete interview (n = 3) (Figure 1). Of the total number of participants randomized (n = 497), 200 met criteria for MN and 297 met criteria for HN. Retention rates by study arm after 24 months are illustrated in Table 2. Different rates are indicated in relation to scales administered every 3 months and every 6 months.

Figure 1.

Figure 1

Participant flow through eligibility, screening, needs level assessment, and allocation to study arm. αIncludes approximately 100 participants deemed ineligible via an informal telephone screen, and 94 participants who were ineligible after formal in-person screening. βIncludes 11 participants who were unable to be located after assignment or left within 1 month of entering.

Table 2.

Follow-up status for 'At Home’ participants after 24 months by need level

Study arm 6 months questionnaire
3 months questionnaire
No follow-up 1
At least one follow up 2
No follow-up 3
At least one follow up 4
Reason
Total (n = 23) Total (n = 474) Reason
Total (n = 16) Total (n = 481)
No contact Death 5 Withdrew consent No contact Death 6 Withdrew consent
High Needs
5
5
-
10
287
3
3
-
6
291
CONG (n = 107)
1
1
-
2
105
-
-
-
-
107
ACT (n = 90)
-
1
-
1
89
-
-
-
-
90
HNTAU (n = 100)
4
3
-
7
93
3
3
-
6
94
Moderate Needs
7
4
2
13
187
6
2
2
10
190
ICM (n = 100)
2
1
-
3
97
2
0
-
2
98
MNTAU (n = 100) 5 3 2 10 90 4 2 2 8 92

1 - No follow-up data collected at any of 6, 12, 18 & 24 months.

2 - No significant differences between study arms was observed in terms of follow up completion rate (Fishers’ exact p values for HN & MN sample were 0.074 and 0.082 respectively).

3 - No follow-up data collected at any of 3, 6, 9, 12, 15, 18, 21 & 24 months visit.

4 - In terms of follow up completion rate, significant differences between study arms was observed for the HN sample, but no significant difference was observed for the MN sample (Fishers’ exact p values for HN & MN sample were 0.002 and 0.101 respectively).

5 - Total number of deaths (n = 29) was as follows: CONG-4; ACT-7; HNTAU-5; ICM-6; & MNTAU-7. However, 20 participants completed at least one follow up visit before death and the remaining 9 participants whose follow up data was not available died with seven months of randomization.

6 - Out of 29 deaths, 5 participants whose follow up data was not available died within five months of randomization and the rest 24 participants completed at least one follow up visit before death.

The primary reasons for loss to follow-up over 24 months were death (n = 5 for 3-month scales and n = 9 for 6-month scales) or inability to locate the participant (n = 9 for 3-month scales and n = 12 for 6-month scales). Some deaths occurred after participants had completed at least one follow-up interview and these data are eligible for analysis. The overall retention rate through 24 months was 97% (Table 2). No significant differences between study arms were observed in terms of follow-up (6-month scales) completion rates (Fisher’s exact P values for HN and MN samples were 0.074 and 0.082, respectively). For the 3-month scales, follow-up completion rates between HN study arms were significantly different (CONG, 100%; HF-ACT, 100%; TAU, 94%; Fisher’s exact P value = 0.002), but no significant difference was observed for the MN sample (HF-ICM, 98%; TAU, 92%; Fisher’s exact P value = 0.101). Of the 497 participants randomized, 438 (88%) gave consent to access administrative data from publicly-funded agencies.

Adverse events of all kinds were reported to a monitoring committee as well as to the Research Ethics Board at Simon Fraser University. Apart from mortality, adverse events typically involved episodes of interpersonal conflict, such as abusive language or offensive behavior involving participants.

Sociodemographic characteristics of participants are detailed in Table 3. Most were male (73%), white (56%), never married (70%), had a current medical illness (91%), were substance dependent (58%), and met criteria for 'absolute homelessness’ (78%).

Table 3.

Socio-demographic and mental disorder related characteristics for the 'At Home’ participants by need status

Variables Overall N (%) HN N (%) MN N (%) P value
Socio-demographics
 
 
 
 
Age at enrolment visit (years)
 
 
 
 
 Mean (SD)
40.8 (11.0)
39.7 (11.2)
42.6 (10.5)
0.004
 Median (IQR)
41 (32–48)
39 (31–47)
44 (36–49)
0.002
Male Gender
359 (73)
218 (74)
141 (71)
0.420
Place of birth (Canada)
431 (87)
256 (87)
175 (88)
0.743
Ethnicity
 
 
 
 
 Aboriginals
77 (16)
44 (15)
33 (16)
0.844
 White
280 (56)
170 (57)
110 (55)
 
 Other
140 (28)
83 (28)
57 (29)
 
Incomplete High School
280 (57)
179 (61)
101 (51)
0.022
Single (never married)
343 (70)
214 (73)
129 (65)
0.043
Have children (under18)
122 (25)
69 (24)
53 (27)
0.483
Native Language (English)
392 (80)
236 (80)
156 (78)
0.696
Homelessness
 
 
 
 
Precariously housed
109 (22)
65 (22)
44 (22)
0.976
Lifetime duration of homelessness (months)
 
 
 
 
 Mean (SD)
60.2 (70.3)
62.0 (67.0)
57.5 (74.9)
0.489
 Median (IQR)
36 (12–84)
42 (12–84)
36 (12–84)
0.179
Longest duration of homelessness (months)
 
 
 
 
 Mean (SD)
30.9 (40.1)
32.2 (40.8)
28.9 (39.1)
0.358
 Median (IQR)
12 (6–36)
18 (6–45)
12 (6–36)
0.236
Age of first homelessness (years)
 
 
 
 
 Mean (SD)
30.3 (13.3)
28.7 (12.5)
32.6 (14.1)
0.002
 Median (IQR)
28 (19–41)
26 (19–36)
34 (20–44)
0.003
Employment
 
 
 
 
 Currently employed
18 (4)
10 (3)
8 (4)
0.722
 Worked continuously (>1 year) in past
323 (65)
185 (63)
138 (69)
0.164
 History of any wartime services
27 (5)
17 (6)
10 (5)
0.697
 Willingness to have paid job
384 (87)
217 (84)
167 (90)
0.102
Hospitalized for mental illness (last 5 years)*
 
 
 
 
 Over 6 months
57 (12)
47 (16)
10 (5)
<0.001
 More than two times
253 (53)
197 (69)
56 (29)
<0.001
MINI International
 
 
 
 
Neuropsychiatric Interview diagnosis
 
 
 
 
 Psychotic Disorder/Schizophrenia*
263 (53)
211 (71)
52 (26)
<0.001
 Major Depressive Episode
199 (40)
95 (32)
104 (52)
<0.001
 Post Traumatic Stress Disorder (PTSD)
129 (26)
63 (21)
66 (33)
0.003
 Manic or Hypomanic Episode*
97 (19)
68 (23)
29 (14)
0.021
 Panic Disorder
104 (21)
59 (20)
45 (22)
0.479
 Mood disorder with psychotic feature
84 (17)
56 (19)
28 (14)
0.152
 Substance Dependence
288 (58)
183 (62)
105 (52)
0.043
 Alcohol Dependence
121 (24)
72 (24)
49 (24)
0.948
 Suicidality (high or moderate)
168 (34)
93 (31)
75 (37)
0.153
 Two or more mental disorders
240 (52)
148(53)
92 (51)
0.402
 Three or more mental disorders
114 (25)
78 (28)
36 (20)
0.032
Referral sources
 
 
 
 
 Shelter or transitional housing
143 (29)
82 (28)
61 (31)
<0.001
 Housing Lists
19 (4)
9 (3)
10 (5)
 
 Outreach
86 (17)
44 (15)
42 (21)
 
 Hospitals
47 (9)
35 (12)
12 (6)
 
 Aboriginal groups
15 (3)
6 (2)
9 (4)
 
 Criminal justice
70 (14)
59 (20)
11 (6)
 
 Drop-in-centers
65 (13)
33 (11)
32 (16)
 
 Mental health teams
19 (4)
13 (4)
6 (3)
 
 Other
16 (3)
6 (2)
10 (5)
 
 Not specified 17 (3) 10 (3) 7 (3)  

* Variables used to determine eligibility for the HN sample.

A number of significant differences between the MN and HN samples were observed (Table 3 and 4). Several differences were expected based on inclusion criteria for each study and are reflected in the results. HN participants were more likely to have a psychotic disorder, have been hospitalized for psychiatric reasons, meet criteria for substance dependence, and have justice system involvement. HN participants also had lower MCAS scores.

Table 4.

Questionnaire related characteristics for 'At Home’ participants by need status at enrolment visit

Questionnaire Overall mean (SD) HN mean (SD) MN mean (SD) P value
Community Integration Scale (CIS)
 
 
 
 
 Physical subscale score
2.1 (1.7)
1.9 (1.7)
2.4 (1.8)
<0.001
 Psychological subscale score
10.9 (3.5)
11.0 (3.5)
10.7 (3.6)
0.368
Colorado Symptom Index (CSI)
 
 
 
 
 Total score
37.2 (12.5)
38.0 (13.1)
36.0 (11.7)
0.098
Comorbid Conditions List (CMC) 1
N (%)
N (%)
N (%)
 
 Asthma
103 (21)
50 (17)
53 (26)
0.009
 Hepatitis C
139 (30)
78 (28)
61 (31)
0.302
 HIV/AIDS
43 (9)
18 (6)
25 (12)
0.012
 Hepatitis B
25 (5)
13 (5)
12 (6)
0.412
 Blood-borne infectious diseases2
157 (32)
87 (30)
70 (35)
0.224
 Epilepsy or seizure
67 (13)
49 (16)
18 (9)
0.016
 Stroke
27 (5)
19 (6)
8 (4)
0.248
 Cancer
18 (4)
14 (5)
4 (2)
0.117
 Head Injury
324 (65)
191 (64)
133 (67)
0.563
 Presence of any physical illness
453 (91)
268 (90)
185 (93)
0.384
 Multiple (≥ 2) physical illness
402 (81)
231 (78)
171 (86)
0.032
 Multiple (≥ 3) physical illness
344 (69)
189 (64)
155 (78)
0.001
EuroQuol 5D (EQ5D)
 
 
 
 
 Overall health
61.0 (22.5)
61.8 (23.1)
60.0 (21.5)
0.382
Food Security (FS)
 
 
 
 
 Total score
4.6 (2.6)
4.5 (2.5)
4.8 (2.7)
0.214
Global Assessment of Individual need –Substance Problem Scale (GAIN-SPS)
 
 
 
 
 Total score (last month)
2.1 (2.0)
2.3 (2.0)
1.8 (2.0)
0.007
 Age of first alcohol use
14.1 (6.3)
14.2 (5.0)
14.1 (4.9)
0.751
 Age of first drug use
15.7 (5.0)
15.5 (5.6)
16.0 (7.2)
0.438
Health Service Access Items (ACC)
 
 
 
 
 Have a regular medical doctor
320 (65)
177 (60)
143 (72)
0.008
 Place to go when you are sick
395 (81)
231 (79)
164 (83)
0.342
 Needed health care, but didn’t receive it
209 (43)
129 (45)
80 (40)
0.269
Health, Social Justice Service Use Inventory (HSJSU)
 
 
 
 
 Seen by a health/social service provider
389 (79)
216 (74)
173 (89)
<0.001
 Visited psychiatrist
134 (27)
89 (30)
45 (22)
0.066
 Talked with a health/social service provider
112 (29)
58 (20)
54 (27)
0.065
 Emergency room visit
281 (58)
163 (56)
118 (60)
0.483
 Ambulance
195 (40)
118 (40)
77 (39)
0.748
 Contacts with police (no arrest)
254 (52)
154 (53)
100 (51)
0.573
 Held in a police cell (≤24 hours)
112 (23)
80 (28)
32 (16)
0.002
 Arrested
173 (36)
128 (44)
45 (23)
<0.001
 Court appearance
174 (36)
123 (43)
51 (26)
<0.001
Interviewer Impression Items (III)
N (%)
N (%)
N (%)
 
 Signs of difficulty in reading response card (a lot)
20 (4)
17 (6)
3 (1)
0.019
 Signs of drug or alcohol intoxication (a lot)
10 (2)
7 (2)
3 (1)
0.505
 Signs of psychiatric symptoms (a lot)
66 (13)
58 (19)
8 (4)
<0.001
 Validity of information (no confidence)
14 (3)
13 (4)
1 (<1)
0.010
Multnomah Community Ability Scale (MCAS)*
 
 
 
 
 Total score
56.1 (9.6)
50.7 (6.8)
64.1 (7.3)
<0.001
SF-12 Health Survey (SF-12)
 
 
 
 
 Physical health
45.9 (12.3)
46.5 (12.4)
45.1 (12.2)
0.233
 Mental health
35.4 (13.7)
35.8 (13.6)
34.8 (13.9)
0.445
Quality of Life Index 20 Item (QOLI-20)
 
 
 
 
 Total score
73.6 (21.9)
74.4 (21.5)
72.5 (22.4)
0.337
Recovery Assessment Scale 22 item (RAS-22)
 
 
 
 
 Total score
79.5 (12.0)
79.2 (11.5)
79.9 (12.8)
0.563
Maudsley Addiction Profile (MAP)
N (%)
N (%)
N (%)
 
 Use of alcohol
225 (46)
142 (48)
83 (42)
0.174
 Use of heroin
96 (19)
59 (20)
37 (19)
0.732
 Use of Cocaine
83 (17)
57 (19)
26 (13)
0.074
 Use of Cocaine-crack base
160 (32)
97 (33)
63 (32)
0.805
 Use of Amphetamine
61 (12)
44 (15)
17 (7)
0.035
 Use of Cannabis
205 (45)
133 (47)
72 (42)
0.256
 Injection drug use
88 (18)
54 (18)
34 (17)
0.727
 Daily drug use (excluding alcohol)
126 (25)
82 (28)
44 (22)
0.159
 Poly drug (≥ 3) use (excluding alcohol) 108 (22) 72 (24) 36 (18) 0.065

1 - Response 'Do not know’ was considered as no.

2 - Included HIV, Hepatitis C & Hepatitis B.

* Variables used to determine eligibility for the HN sample.

Beyond differences that were directly related to inclusion criteria (indicated with asterisk in Table 3 and Table 4), a number of additional significant differences between MN and HN were observed. MN participants were older at recruitment and when first homeless, were more likely to have been married, and more likely to have completed high school than those in the HN sample. Participants in the MN sample were more likely to report multiple physical illnesses, asthma, and HIV/AIDS than those in the HN sample.

Results of standardized questionnaires indicate broad similarities between the MN and HN samples (Table 4). No significant differences between groups were observed on measures of: community integration (CIS total score), health-related quality of life (EQ-5D), food security (FS), overall health (SF-12, physical or mental health scores), overall quality of life (QoLI-20), and personal recovery (RAS-22). The MN sample reported significantly greater physical integration in the community (CIS physical) and a significantly lower level of externalizing or substance-related needs (GAIN-SPS) than the HN sample.

A series of comparisons tested for potential non-equivalence between randomization arms at baseline. Sociodemographic and diagnostic characteristics for the three HN and two MN study arms are shown in Table 5. Within the HN sample, there were no significant baseline differences of sociodemographics and mental disorders between groups. In the MN sample, those randomized to TAU had longer durations of homelessness (P = 0.037) and were more likely to be absolutely homeless (P = 0.041) at the time of recruitment. Further comparisons of questionnaire results indicate no meaningful differences between randomization arms in either the MN or HN study, except for several comorbid medical conditions (HIV, hepatitis B, cancer). HN participants randomized to CONG had a significantly higher prevalence of HIV and hepatitis B, but when all blood-borne diseases (HIV, hepatitis B and C) were combined, no significant differences were observed between groups (Table 6).

Table 5.

Comparisons of Socio-demographic and mental disorder related characteristics between study arms

Variable High need (n = 297)
Moderate need (n = 200)
CONG (n = 107) N (%) ACT (n = 90) N (%) TAU (n = 100) N (%) P value 1 ICM (n = 100) N (%) TAU (n = 100) N (%) P value 2
Socio-Demographics
 
 
 
 
 
 
 
Age at randomization (years)
 
 
 
 
 
 
 
 Mean (SD)
40.0 (11.6)
39.5 (10.8)
39.5 (11.2)
0.910
42.1 (10.4)
43.1(10.6)
0.475
 Median (IQR)
41 (30–48)
38 (31–47)
39 (32–48)
0.920
43 (34–50)
45 (36–49)
0.610
Male gender
82 (77)
66 (74)
70 (71)
0.696
71 (71)
70 (71)
0.964
Ethnicity
 
 
 
 
 
 
 
 Aboriginals
21 (20)
11 (12)
12 (12)
0.469
19 (19)
14 (14)
0.060
 Caucasian
60 (56)
53 (59)
57 (57)
 
60 (60)
50 (50)
 
 Mixed/Other
26 (24)
26 (29)
31 (31)
 
21 (21)
36 (36)
 
Incomplete high school
70 (66)
47 (53)
62 (62)
0.192
56 (56)
45 (45)
0.120
Single/Never married
76 (72)
63 (70)
75 (77)
0.591
66 (66)
63 (63)
0.658
Birth country (Canada)
94 (88)
80 (89)
82 (83)
0.417
90 (90)
85 (85)
0.285
Have children (under18)
24 (23)
21 (24)
24 (25)
0.938
28 (28)
25 (25)
0.692
Native Language (English)
87 (81)
76 (84)
73 (73)
0.125
13 (13)
16 (16)
0.733
Homelessness
 
 
 
 
 
 
 
Absolutely homeless
88 (82)
72 (80)
72 (72)
0.179
72 (72)
84 (84)
0.041
Lifetime duration of homelessness (months)
 
 
 
 
 
 
 
 Mean (SD)
52.2 (63.5)
61.5 (69.1)
67.6 (69.0)
0.541
68.5 (92.1)
46.4 (50.7)
0.037
 Median (IQR)
36 (12–72)
42 (12–84)
48 (13–109)
0.575
48 (14–93)
24 (12–72)
0.051
Longest duration of homelessness (months)
 
 
 
 
 
 
 
 Mean (SD)
32.9 (39.3)
30.5 (42.7)
33.0 (41.0)
0.901
31.7 (43.7)
26.0 (33.9)
0.304
 Median (IQR)
20 (7–48)
12 (6–40)
12 (6–48)
0.623
48 (6–40)
12 (5–34)
0.321
Age of first homelessness (years)
 
 
 
 
 
 
 
 Mean (SD)
29.9 (13.1)
28.0 (11.9)
28.0 (12.4)
0.474
30.8 (13.8)
34.3 (14.3)
0.083
 Median (1QR)
27 (20–39)
26 (19–35)
24 (18–36)
0.463
29 (18–42)
35 (21–45)
0.118
Employment
 
 
 
 
 
 
 
 Currently employed
5 (5)
1 (1)
4 (4)
0.368*
6 (6)
2 (2)
0.279*
 Worked continuously (>1 year) in past
66 (62)
58 (69)
61 (61)
0.773
66 (66)
72 (72)
0.987
 Wartime services in past
4 (4)
7 (8)
6 (6)
0.448
5 (5)
5 (5)
0.987
 Willingness to have paid job
79 (82)
68 (90)
70 (82)
0.353
80 (89)
87 (91)
0.696
Hospitalized for mental illness (last 5 years)
 
 
 
 
 
 
 
 Over 6 months
14 (13)
18 (20)
15 (15)
0.406
4 (4)
6 (6)
0.506
 More than two times
73 (70)
57 (68)
67 (71)
0.927
25 (25)
31 (32)
0.299
MINI International Neuropsychiatric Interview diagnosis
 
 
 
 
 
 
 
 Major Depressive Episode
35 (33)
31 (34)
29 (29)
0.710
52 (52)
52 (52)
1.00
 Manic or Hypomanic Episode
25 (23)
23 (26)
20 (20)
0.654
11 (11)
18 (18)
0.160
 Post-Traumatic Stress Disorder
27 (25)
17 (19)
19 (19)
0.445
34 (34)
32 (32)
0.802
 Panic Disorder
20 (19)
15 (17)
24 (24)
0.418
19 (19)
26 (26)
0.236
 Mood Disorder with psychotic feature
20 (19)
17 (19)
19 (19)
0.997
16 (16)
12 (12)
0.415
 Psychotic Disorder
79 (74)
59 (66)
73 (73)
0.385
25 (25)
27 (27)
0.747
 Alcohol dependence
28 (26)
19 (21)
25 (25)
0.695
25 (25)
24 (24)
0.869
 Substance dependence
67 (63)
55 (61)
61 (61)
0.965
51 (51)
54 (54)
0.671
 Suicidality (moderate or high)
34 (32)
28 (31)
31 (31)
0.992
33 (33)
42 (42)
0.189
 Two or more mental disorders
53 (49)
41 (46)
54 (54)
0.507
44 (44)
48 (48)
0.547
 Three or more mental disorders
34 (32)
22 (24)
22 (22)
0.250
17 (17)
19 (19)
0.713
Referral sources
 
 
 
 
 
 
 
 Shelter or transitional housing
31 (29)
26 (29)
25 (25)
0.468
31 (31)
30 (30)
0.250
 Housing Lists
3 (3)
4 (4)
2 (2)
 
6 (6)
4 (4)
 
 Outreach
13 (12)
15 (17)
16 (16)
 
21 (21)
21 (21)
 
 Hospitals
11 (10)
11 (12)
13 (13)
 
4 (4)
8 (8)
 
 Aboriginal groups
2 (2)
2 (2)
2 (2)
 
6 (6)
3 (3)
 
 Criminal justice
27 (25)
14 (16)
18 (18)
 
5 (5)
6 (6)
 
 Drop-in-centers
15 (14)
9 (10)
9 (6)
 
20 (20)
12 (12)
 
 Mental health teams
4 (4)
3 (3)
6 (6)
 
0 (0)
6 (6)
 
 Other
0 (0)
1 (1)
5 (5)
 
4 (4)
6 (6)
 
 Not specified 1 (1) 5 (6) 4 (4)   3 (3) 4 (4)  

1 - Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.

2 - Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.

* - P value from Fisher’s Exact Test.

Table 6.

Comparisons of questionnaire related characteristics between study arms at enrolment visit

Questionnaire High need (n = 297)
Moderate need (n = 200)
CONG (n = 107) N (%) or Mean (SD) ACT (n = 90) N (%) or Mean (SD) TAU (n = 100) N (%) or Mean (SD) P value 1 ICM (n = 100) N (%) or Mean (SD) TAU (n = 100) N (%) or Mean (SD) P value 2
Community Integration Scale (CIS)
 
 
 
 
 
 
 
 Physical subscale score
2.1 (1.8)
1.6 (1.5)
1.8 (1.7)
0.148
2.5 (1.8)
2.4 (1.7)
0.884
 Psychological subscale score
10.6 (3.7)
11.3 (3.5)
11.1 (3.2)
0.384
10.4 (3.5)
11.0 (3.6)
0.241
Colorado Symptom Index (CSI)
 
 
 
 
 
 
 
 Total score
37.1 (13.0)
36.4 (13.4)
40.2 (12.6)
0.093
36.1 (12.2)
36.0 (11.2)
0.954
Comorbid Conditions List (CMC) 3
N (%)
N (%)
N (%)
 
N (%)
N (%)
 
 Asthma
18 (17)
14 (16)
18 (18)
0.904
27 (27)
26 (26)
0.873
 Hepatitis C
26 (24)
23 (26)
29 (29)
0.732
32 (32)
29 (29)
0.645
 HIV/AIDS
12 (11)
2 (2)
4 (4)
0.025*
16 (16)
9 (9)
0.134
 Hepatitis B
9 (8)
1 (1)
3 (3)
0.039*
7 (7)
5 (5)
0.552
 Blood-borne infectious diseases4
33 (32)
23 (26)
31 (32)
0.572
37 (37)
33 (33)
0.553
 Epilepsy or seizure
20 (19)
10 (11)
19 (19)
0.256
5 (5)
13 (13)
0.081*
 Stroke
11 (10)
2 (2)
6 (6)
0.069
2 (2)
6 (6)
0.279*
 Cancer
4 (4)
1 (1)
9 (9)
0.036*
0 (0)
4 (4)
0.058*
 Head Injury
66 (62)
62 (69)
63 (63)
0.544
61 (61)
72 (73)
0.079
 Presence of any physical illness
98 (92)
81 (90)
89 (89)
0.818
90 (90)
95 (95)
0.179
 Multiple (≥ 2) physical illness
82 (77)
69 (77)
80 (80)
0.806
84 (84)
87 (87)
0.547
 Multiple (≥ 3) physical illness
69 (65)
52 (58)
68 (68)
0.334
78 (78)
77 (77)
0.866
EuroQuol 5D (EQ5D)
 
 
 
 
 
 
 
 Overall health
59.5 (23.7)
64.2 (22.9)
62.0 (22.5)
0.361
58.4 (23.4)
61.5 (19.5)
0.325
Food Security (FS)
 
 
 
 
 
 
 
 Total score
4.3 (2.6)
4.4 (2.6)
4.8 (2.4)
0.454
4.7 (2.8)
4.8 (2.7)
0.799
Global Assessment of Individual need –Substance Problem Scale (GAIN-SPS)
 
 
 
 
 
 
 
 Total score (last month)
2.4 (2.0)
2.1 (1.9)
2.3 (2.0)
0.591
1.8 (2.0)
1.8 (2.0)
0.842
 Age of first alcohol use
14.3 (6.5)
14.2 (3.8)
14.2 (4.0)
0.979
13.8 (4.8)
14.3 (4.9)
0.523
 Age of first drug use
15.6 (6.5)
15.3 (5.0)
15.7 (5.0)
0.892
15.4 (6.3)
16.5 (7.9)
0.304
Health Service Access Items (ACC)
 
 
 
 
 
 
 
 Have a regular medical doctor
64 (60)
53 (59)
60 (61)
0.971
71 (71)
72 (72)
0.876
 Place to go when you are sick
82 (80)
72 (81)
77 (79)
0.913
83 (84)
81 (82)
0.706
 Needed health care, but didn’t receive it
45 (43)
36 (41)
48 (51)
0.371
39 (39)
41 (41)
0.817
Health, Social Justice Service Use Inventory (HSJSU)
N (%)
N (%)
N (%)
 
N (%)
N (%)
 
 Seen a health/social service provider
70 (66)
67 (75)
79 (80)
0.075
84 (84)
89 (90)
0.217
 Visited psychiatrist
28 (26)
27 (30)
34 (34)
0.470
20 (20)
25 (25)
0.397
 Talked a health/social service provider
12 (20)
18 (20)
19 (20)
0.992
31 (31)
23 (23)
0.218
 Emergency room visit
59 (57)
51 (57)
53 (54)
0.912
64 (64)
54 (55)
0.202
 Ambulance
47 (44)
33 (37)
38 (38)
0.535
35 (35)
42 (38)
0.282
 Contacts with police (no arrest)
53 (52)
42 (47)
59 (60)
0.226
45 (45)
55 (56)
0.118
 Held in a police cell (≤24 hours)
25 (24)
27 (31)
28 (30)
0.556
14 (14)
18 (19)
0.386
 Arrested
50 (48)
32 (36)
46 (48)
0.152
19 (19)
26 (27)
0.179
 Court appearance
51 (50)
34 (38)
38 (40)
0.189
22 (22)
29 (30)
0.222
Interviewer Impression Items (III)
N (%)
N (%)
N (%)
 
N (%)
N (%)
 
 Signs of difficulty in reading card (a lot)
6 (6)
6 (7)
5 (5)
0.883
2 (2)
1 (1)
1.00*
 Signs of drug or alcohol intoxication (a lot)
1 (1)
2 (2)
4 (4)
0.349*
1 (1)
2 (2)
1.00*
 Signs of psychiatric symptoms (a lot)
25 (23)
11 (12)
22 (22)
0.108
4 (4)
4 (4)
1.00*
 Validity of information (no confidence)
7 (6)
4 (4)
2 (2)
0.287*
1 (1)
0 (0)
1.00*
Multnomah Community Ability Scale (MCAS)
 
 
 
 
 
 
 
 Total score
49.9.0 (6.7)
51.6 (6.5)
50.6 (7.0)
0.195
64.1 (7.6)
64.1 (7.1)
0.962
SF-12 Health Survey (SF-12)
 
 
 
 
 
 
 
 Physical health
47.4 (13.1)
46.7 (12.3)
45.3 (11.6)
0.466
43.9 (12.1)
46.4 (12.9)
0.140
 Mental health
34.8 (15.1)
36.9 (13.0)
35.8 (12.6)
0.551
35.7 (13.0)
33.9 (14.8)
0.371
Quality of Life Index 20 Item (QOLI-20)
 
 
 
 
 
 
 
 Total score
72.6 (21.7)
76.2 (21.3)
74.7 (21.4)
0.497
72.2 (21.6)
72.8 (23.3)
0.851
Recovery Assessment Scale 22 item (RAS-22)
 
 
 
 
 
 
 
 Total score
78.2 (12.1)
80.7 (11.5)
79.1 (10.7)
0.308
80.3 (11.3)
79.5 (14.1)
0.685
Maudsley Addiction Profile (MAP)
N (%)
N (%)
N (%)
 
N (%)
N (%)
 
 Use of alcohol
50 (47)
44 (49)
48 (49)
0.936
37 (38)
46 (46)
0.240
 Use of heroin
24 (22)
13 (14)
22 (22)
0.295
18 (18)
19 (19)
0.909
 Use of Cocaine
24 (22)
14 (16)
19 (19)
0.476
12 (12)
14 (14)
0.715
 Use of Cocaine-crack base
36 (34)
26 (29)
35 (36)
0.596
36 (37)
27 (27)
0.141
 Use of Amphetamine
12 (11)
17 (18)
15 (15)
0.346
10 (10)
7 (7)
0.421
 Use of Cannabis
46 (45)
40 (48)
47 (49)
0.848
35 (42)
37 (42)
0.960
 Injection drug use
19 (18)
16 (18)
19 (20)
0.944
18 (18)
16 (16)
0.682
 Daily drug use (excluding alcohol)
31 (29)
19 (21)
32 (32)
0.227
27 (27)
17 (17)
0.088
 Poly drug (≥ 3) use (excluding alcohol) 30 (28) 17 (29) 25 (25) 0.318 20 (20) 16 (16) 0.421

1 -Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.

2 -Bold indicates p value ≤ 0.05 and Italic indicates p value between > 0.05 and ≤ 0.1.

2 -Response 'Do not know’ was considered as no.

4 -Included HIV, Hepatitis C & Hepatitis B.

* -P value from Fisher’s Exact Test.

Discussion

As expected, inclusion criteria led to a number of significant differences between the MN and HN samples. Compared to those in MN, members of the HN cohort were significantly more likely to meet criteria for psychosis or mania/hypomania, have multiple recent psychiatric hospitalizations, and be severely compromised in their community functioning. Other significant differences between MN and HN were not directly related to the inclusion/exclusion criteria. Members of the HN cohort had lower educational achievement and were more likely to have multiple mental disorders than those assigned to the MN study. In numerous other respects, participants assigned to MN and HN did not differ significantly. Overall, participants were white, male, 'absolutely homeless’, physically ill, and met criteria for substance dependence and alcohol dependence.

Participants assigned to MN were significantly more likely to meet criteria for post-traumatic stress disorder, major depression, and report having HIV/AIDS than those assigned to HN. Thirty percent of the MN cohort had been homeless for more than 60 months in their lifetime and 26% met criteria for a psychotic disorder. These results suggest that the descriptor 'moderate’ is a misnomer that understates the complexity of needs within the MN cohort. As hypothesized, the profile of both study cohorts (MN and HN) included level of needs (for example, substance dependence, physical illness) that have not been included in previous studies of HF. VAH is therefore capable of generating new knowledge regarding the effectiveness of HF-ICM and HF-ACT for clients with a broad range of presenting characteristics.

Randomization successfully minimized differences between study arms. We tested for differences on sociodemographic and mental health-related variables, as well as all other measures (total score or subscale score or individual item) administered at baseline. In the MN study, those assigned to the TAU arm were significantly more likely to be 'absolutely homeless’ and to have lower lifetime duration of homelessness. No other significant differences were observed in either study, except for several comorbid medical conditions (HIV, hepatitis B, cancer) with very low prevalence. HN participants randomized to CONG had a significantly higher prevalence of HIV and hepatitis B, but when all blood-borne diseases (HIV, hepatitis B and C) were combined, no significant differences were observed between groups. Despite differences between groups, the low prevalence of these conditions in the sample is not expected to influence results. However, tests will be designed to control for relevant differences identified at baseline. Previous research has indicated that homeless mentally ill individuals may have a preference for independent apartments over group housing when offered a choice [83], and that these preferences may change based on experiences after the initiation of housing [84]. In the present study, individuals randomized to HF-ACT had a choice of apartments, but those randomized to CONG were limited to selecting from among the available units in one building. Narrative interviews will be examined in order to assess whether participants experienced meaningful differences concerning their choice of housing in either of these two settings, and whether the experience of choice was related to outcomes of interest.

A high percentage of participants in each study arm (92% to 100%) were successfully followed through 24 months of interviews. Twenty-nine participants died during the 24 months following randomization. Unsurprisingly, participants assigned to TAU were most likely to be lost to follow-up during the 24 months post-randomization. However, the differences were not statistically significant. Differences in follow-up for the 3-month scales were significant in the HN study only. Despite statistically significant differences, the high overall follow-up rate in each group (94% in one arm, 100% in two others) is expected to yield valid and generalizable results. This high follow-up rate is attributable to diverse strategies, including extensive outreach, a welcoming field office, relationships with service providers in the field, and maintaining updated information regarding collateral contacts and daily routines. More generally, the recruitment and retention of a knowledgeable and committed team of interviewers is a critical factor.

VAH shares several important methodological features with studies in four other Canadian sites, primarily: inclusion/exclusion criteria, randomization to HF or usual care, a common battery of cross-site measures, and semi-structured qualitative interviews with a subset of participants [1]. At the same time, the current study has a number of important site-specific elements. VAH is the only RCT to compare different configurations of HF (congregate and scattered sites) alongside TAU. The results of this comparison will offer guidance to many cities, including Vancouver, that include congregate variations of HF as part of their strategies to address homelessness [85]. In addition, this trial has recruited samples with a broader range and severity of symptoms than those reflected in previous studies. For example, the high prevalence of substance use disorders in this study will help to fill a specific gap in knowledge regarding the robustness of HF for individuals with concurrent disorders [86].

A number of unique measures were incorporated in the protocol based on their expected relevance to the local population, including measures of addiction frequency and severity, neuropsychological functioning, and physical examinations. In addition, VAH incorporates a large array of administrative data spanning diverse publicly-funded services and interventions across time. These data generate opportunities to study the trajectories of service involvement over 10 years prior to recruitment in VAH, and enable follow-up of participants after the completion of the intervention. The inclusion of longitudinal data from multiple relevant sectors (justice, health, financial assistance) provides a unique opportunity for cost-based analyses.

This study combines models of housing with support in each of the intervention conditions. This may make it difficult to isolate the relative contribution of distinct components (for example, housing alone) that best account for any observed differences or improvements. Each of the data sources included in the VAH protocol is subject to sources of bias. Several questionnaires have not been well validated with homeless mentally ill samples, and a small number were adapted or developed for the present study. Narrative interviews with selected participants may yield findings that are unrepresentative. Administrative data sources are subject to limitations that include the ability to match all subjects across all databases, and the accuracy and completeness of the resulting extracts. However, the combination of administrative data, narrative interviews, and questionnaires enables the application of mixed-methods approaches that enrich understanding beyond the scope of each individual data type. Finally, while other sites abbreviated their study durations to 21 months, VAH maintained the original 24-month protocol, and therefore preserved a greater opportunity to detect changes that may require a longer period of observation.

Conclusions

The present results confirm that VAH has successfully implemented experimental protocols that promise to generate new knowledge regarding interventions for individuals who are both homeless and mentally ill. Participants were successfully recruited and retained through the follow-up period, and randomization effectively minimized differences between study arms in each trial. Diverse data sources and relatively long follow-up provide opportunities for multi-method approaches to longitudinal data analysis. VAH adds to previous research on HF by including a sample with complex comorbidities and concurrent substance use disorders, and is the first experiment to include congregate housing alongside scattered site HF.

Abbreviations

ACC: Health service access items; ACE: adverse childhood experiences; ACT: Assertive community treatment; ANOVA: Analysis of variance; CI: Cognitive impairment; CIS: Community integration scale; CMC: Comorbid conditions list; CONG: Congregate housing with support; CONSORT: Consolidated standards of reporting trials; CSI: Colorado symptom index (modified); C-SSS: Core service satisfaction scale; CTS: Conflict tactics scale; EQ-5D: EuroQol 5D; FS: Social support items and food security; GAIN-SPS: Global appraisal of individual needs, substance problem scale; GEE: Generalized estimating equation; HF: Housing first; HLM: Hierarchical linear modeling; HN: High needs; HSJSU: health, social, and justice service use inventory; ICM: Intensive case management; LR: Landlord relations; MAP: Maudsley addiction profile; MCAS: Multnomah community ability scale; MH: Mobility history; MINI: Mini-international neuropsychiatric interview; MN: Moderate needs; MoCA: Montreal cognitive assessment; OHQS: Observer-rated housing quality scale; PHQL: Perceived housing quality; QoLI-20: Quality of life index, 20-item; RAS-22: Recovery assessment scale, 22-item; RCT: Randomized controlled trial; RTLFB: Residential time-line follow-back; SF-12: SF-12 health survey; SRO: Single room occupancy; TAU: Treatment as usual; VAH: Vancouver at home; VFC: Foster care history; VTLFB: Vocational time-line follow-back; WAI: Working alliance inventory.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JMS is lead investigator of the study, and drafted and finalized the manuscript. MLP oversaw field research and wrote sections of the manuscript. AM conducted statistical analyses and prepared results for the manuscript. LC administered interviews and prepared sections of the manuscript. SNR contributed to data analysis and prepared sections of the manuscript. AP contributed to the design of the study and edited the manuscript. KF contributed to the design and implementation of the study. All authors read and approved the final manuscript.

Contributor Information

Julian M Somers, Email: jsomers@sfu.ca.

Michelle L Patterson, Email: mlpatter@sfu.ca.

Akm Moniruzzaman, Email: amoniruz@sfu.ca.

Lauren Currie, Email: clauren@sfu.ca.

Stefanie N Rezansoff, Email: sra20@sfu.ca.

Anita Palepu, Email: apalepu@hivnet.ubc.ca.

Karen Fryer, Email: kfryer@sfu.ca.

Acknowledgments

Special thanks to the Vancouver At Home participants, service providers, and field research team members. The authors also thank the At Home/Chez Soi project collaborative. This research was funded by a grant to Simon Fraser University from Health Canada and the Mental Health Commission of Canada. The views expressed herein solely represent the authors.

References

  1. Goering PN, Streiner DL, Adair C, Aubry T, Barker J, Distasio J, Hwang SW, Komaroff J, Latimer E, Somers J, Zabkiewicz DM. The At Home/Chez Soi trial protocol: a pragmatic, multi-site, randomised controlled trial of a Housing First intervention for homeless individuals with mental illness in five Canadian cities. BMJ Open. 2011;1:e000323–e000323. doi: 10.1136/bmjopen-2011-000323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell L, Boyd N, Culburt L. A Thousand Dreams: Vancouver’s Downtown Eastside and the Fight for its Future. Vancouver, BC: Greystone Books; 2009. [Google Scholar]
  3. Foley D. Hellish conditions at single-room occupancy hotels. Body Posit. 1998;11:18–23. [PubMed] [Google Scholar]
  4. Shannon K, Ishida T, Lai C, Tyndall MW. The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver. Int J Drug Policy. 2006;17:107–114. doi: 10.1016/j.drugpo.2005.09.002. [DOI] [Google Scholar]
  5. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366:316–318. doi: 10.1016/S0140-6736(05)66475-6. [DOI] [PubMed] [Google Scholar]
  6. Harvey E, Strathdee SA, Patrick DM, Ofner M, Archibald CP, Eades G, O’Shaughnessy MV. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 1998;10:313–321. doi: 10.1080/713612412. [DOI] [PubMed] [Google Scholar]
  7. Palepu A, Tyndall MW, Leon H, Muller J, O’Shaughnessy MV, Schechter MT, Anis AH. Hospital utilization and costs in a cohort of injection drug users. CMAJ. 2001;165:415–420. [PMC free article] [PubMed] [Google Scholar]
  8. Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PGA, Rekart M, Schechter MT, O’Shaughnessy MV. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addict. 1997;92:1339–1348. doi: 10.1111/j.1360-0443.1997.tb02852.x. [DOI] [PubMed] [Google Scholar]
  9. Kushel MB, Perry S, Bangsberg D, Clark R, Moss AR. Emergency department use among the homeless and marginally housed: results from a community-based study. Am J Public Health. 2002;92:778–784. doi: 10.2105/AJPH.92.5.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gilmer TP, Stefancic A, Ettner SL, Manning WG, Tsemberis S. Effect of full-service partnerships on homelessness, use and costs of mental health services, and quality of life among adults with serious mental illness. Arch Gen Psychiatry. 2010;67:645–652. doi: 10.1001/archgenpsychiatry.2010.56. [DOI] [PubMed] [Google Scholar]
  11. Gulcur L, Stefancic A, Shinn M, Tsemberis S, Fischer SN. Housing, hospitalization, and cost outcomes for homeless individuals with psychiatric disabilities participating in continuum of care and housing first programmes. J Comm App Soc Psychol. 2003;13:171–186. doi: 10.1002/casp.723. [DOI] [Google Scholar]
  12. Yanos PT, Felton BJ, Tsemberis S, Frye VA. Exploring the role of housing type, neighborhood characteristics, and lifestyle factors in the community integration of formerly homeless persons diagnosed with mental illness. J Ment Health. 2007;16:703–717. doi: 10.1080/09638230701496378. [DOI] [Google Scholar]
  13. Siegel C, Samuels J, Tang D-I, Berg I, Jones K, Hopper K. Tenant outcomes in supported housing and community residences in New York City. Psychiatr Serv. 2006;57:982–991. doi: 10.1176/appi.ps.57.7.982. [DOI] [PubMed] [Google Scholar]
  14. Tsemberis S, Eisenberg RF. Pathways to housing: supported housing for street-dwelling homeless individuals with psychiatric disabilities. Psychiatr Serv. 2000;51:487–493. doi: 10.1176/appi.ps.51.4.487. [DOI] [PubMed] [Google Scholar]
  15. Stein LI, Test MA. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry. 1980;37:392–397. doi: 10.1001/archpsyc.1980.01780170034003. [DOI] [PubMed] [Google Scholar]
  16. Bond G, Drake R, Mueser K, Latimer E. Assertive community treatment for people with severe mental illness: critical ingredients and impact on patients. Dis Manag Health Outcomes. 2001;9:141–159. doi: 10.2165/00115677-200109030-00003. [DOI] [Google Scholar]
  17. Marshall M, Lockwood A. Assertive Community Treatment for People with Severe Mental Disorders. Chichester: John Wiley & Sons; 1998. [Google Scholar]
  18. Lipton FR, Siegel C, Hannigan A, Samuels J, Baker S. Tenure in supportive housing for homeless persons with severe mental illness. Psychiatr Serv. 2000;51:479–486. doi: 10.1176/appi.ps.51.4.479. [DOI] [PubMed] [Google Scholar]
  19. Fichter MM, Quadflieg N. Intervention effects of supplying homeless individuals with permanent housing: a 3-year prospective study. Acta Psychiatr Scand. 2006;113:36–40. doi: 10.1111/j.1600-0447.2005.00715.x. [DOI] [PubMed] [Google Scholar]
  20. Wong Y-LI, Hadley TR, Culhane DP, Poulin SR, Davis MR, Cirksey BA, Brown JL. Predicting Staying in or Leaving Permanent Supportive Housing that Serves Homeless People with Serious Mental Illness. US Department of Housing and Urban Development: Washington, DC; 2006. [Google Scholar]
  21. Larimer ME, Malone DK, Garner MD, Atkins DC, Burlingham B, Lonczak HS, Tanzer K, Ginzler J, Clifasefi SL, Hobson WG, Marlatt GA. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301:1349–1357. doi: 10.1001/jama.2009.414. [DOI] [PubMed] [Google Scholar]
  22. Schutt RK. Homelessness, Housing, and Mental Illness. Cambridge, MA: Harvard University Press; 2011. [Google Scholar]
  23. Schutt RK, Hough RL, Goldfinger SM, Lehman AF, Shern DL, Valencia E, Wood PA. Lessening homelessness among persons with mental illness: A comparison of five randomized treatment trials. Asian J, Psychiatry. 2009;2:100–105. doi: 10.1016/j.ajp.2009.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:20–33. doi: 10.4088/JCP.v59n0105. [DOI] [PubMed] [Google Scholar]
  25. Barker S, Barron ND, McFarland BH, Bigelow DD, Carnahan TM. A community ability scale for chronically mentally Ill consumers: Part II. Applications. Community Ment Health J. 1994;30:459–472. doi: 10.1007/BF02189063. [DOI] [PubMed] [Google Scholar]
  26. Khandor EE, Mason KK, Chambers CC, Rossiter KK, Cowan LL, Hwang SWS. Access to primary health care among homeless adults in Toronto, Canada: results from the Street Health survey. Open Med. 2011;5:e94–e103. [PMC free article] [PubMed] [Google Scholar]
  27. Hwang SW, Ueng JJM, Chiu S, Kiss A, Tolomiczenko G, Cowan L, Levinson W, Redelmeier DA. Universal health insurance and health care access for homeless persons. Am J Public Health. 2010;100:1454–1461. doi: 10.2105/AJPH.2009.182022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prev Med. 1998;14:245–258. doi: 10.1016/S0749-3797(98)00017-8. [DOI] [PubMed] [Google Scholar]
  29. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test – Revised: Normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55. doi: 10.1076/clin.12.1.43.1726. [DOI] [Google Scholar]
  30. Brandt J. The hopkins verbal learning test: Development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5:125–142. doi: 10.1080/13854049108403297. [DOI] [Google Scholar]
  31. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–276. [Google Scholar]
  32. Wechsler D. Wechsler Adult Intelligence Scale. 4. London: Pearson; 2008. [Google Scholar]
  33. Aubry T, Myner J. Community integration and quality of life: a comparison of persons with psychiatric disabilities in housing programs and community residents who are neighbors. Can J Commun Ment Health. 1996;15:5–20. doi: 10.7870/cjcmh-1996-0001. [DOI] [PubMed] [Google Scholar]
  34. Segal SP, Aviram U. The Mentally Ill in Community-Based Sheltered Care. Chichester: John Wiley & Sons; 1978. [Google Scholar]
  35. Chavis DM, Hogge JH, McMillan DW, Wandersman A. Sense of community through Brunswick’s lens: A first look. J Community Psychol. 1986;14:24–40. doi: 10.1002/1520-6629(198601)14:1&#x0003c;24::AID-JCOP2290140104&#x0003e;3.0.CO;2-P. [DOI] [Google Scholar]
  36. Boothroyd RA, Chen HJ. The psychometric properties of the Colorado Symptom Index. Adm Policy Ment Health. 2008;35:370–378. doi: 10.1007/s10488-008-0179-6. [DOI] [PubMed] [Google Scholar]
  37. Shern DL, Wilson NZ, Coen AS, Patrick DC, Foster M, Bartsch DA, Demmler J. Client outcomes II: Longitudinal client data from the Colorado treatment outcome study. Milbank Q. 1994;72:123–148. doi: 10.2307/3350341. [DOI] [PubMed] [Google Scholar]
  38. Conrad KJ, Yagelka JR, Matters MD, Rich AR, Williams V, Buchanan M. Reliability and validity of a modified Colorado Symptom Index in a national homeless sample. Ment Health Serv Res. 2001;3:141–153. doi: 10.1023/A:1011571531303. [DOI] [PubMed] [Google Scholar]
  39. Greenwood RM, Schaefer-McDaniel NJ, Winkel G, Tsemberis SJ. Decreasing psychiatric symptoms by increasing choice in services for adults with histories of homelessness. Am J Community Psychol. 2005;36:223–238. doi: 10.1007/s10464-005-8617-z. [DOI] [PubMed] [Google Scholar]
  40. Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The Revised Conflict Tactics Scales (CTS2): Development and preliminary psychometric data. J Fam Issues. 1996;17:283–316. doi: 10.1177/019251396017003001. [DOI] [Google Scholar]
  41. Mares AS, Greenberg GA, Rosenheck RA. HUD/HHS/VA Collaborative Initiative to Help End Chronic Homelessness: National Performance Outcomes Assessment: Is System Integration Associated with Client Outcomes? West Haven, CT: Northeast Program Evaluation Center; 2007. [Google Scholar]
  42. Adair CE, McDougall GM, Mitton CR, Joyce AS, Wild TC, Gordon A, Costigan N, Kowalsky L, Pasmeny G, Beckie A. Continuity of care and health outcomes among persons with severe mental illness. Psychiatr Serv. 2005;56:1061–1069. doi: 10.1176/appi.ps.56.9.1061. [DOI] [PubMed] [Google Scholar]
  43. Maruish ME. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. London: Routledge: Instruments for Adults. 3rd edition; 2004. [Google Scholar]
  44. Goering P. Making a Difference: Ontario’s Community Mental Health Evaluation Initiative. Community Mental Health Evaluation Initiative: Toronto, ON; 2004. [Google Scholar]
  45. Lamers LM, Bouwmans CAM, van Straten A, Donker MCH, Hakkaart L. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 2006;15:1229–1236. doi: 10.1002/hec.1125. [DOI] [PubMed] [Google Scholar]
  46. EuroQol Group. EuroQol A new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9. [DOI] [PubMed] [Google Scholar]
  47. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72. doi: 10.1016/0168-8510(96)00822-6. [DOI] [PubMed] [Google Scholar]
  48. Dickens CM, McGowan L, Percival C, Douglas J, Tomenson B, Cotter L, Heagerty A, Creed FH. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart. 2004;90:518–522. doi: 10.1136/hrt.2003.011668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. United States Department of Agriculture (USDA) USDA Adult Food Security Survey Module. Washington, DC: USDA; 2008. [Google Scholar]
  50. Dennis ML, Chan Y-F, Funk RR. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am J Addict. 2006;15:80–91. doi: 10.1080/10550490601006055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Dennis ML, White MK, Titus JC, Unsicker JI. Global Appraisal of Individual Needs (GAIN) Bloomington, IL: Chestnut Health Systems: Administration Guide for the GAIN and Related Measures (Version 5); 2006. [Google Scholar]
  52. Guerriere DN, Ungar WJ, Corey M, Croxford R, Tranmer JE, Tullis E, Coyte PC. Evaluation of the ambulatory and home care record: Agreement between self-reports and administrative data. J of Inter Tech of Health Care. 2006;22:203–210. doi: 10.1017/S0266462306051026. [DOI] [PubMed] [Google Scholar]
  53. Kashner TM, Stensland MD, Lind L, Wicker A, Rush AJ, Golden RM, Henley SS. Measuring use and cost of care for patients with mood disorders. Med Care. 2009;47:184–190. doi: 10.1097/MLR.0b013e31818457b8. [DOI] [PubMed] [Google Scholar]
  54. Sirey JA, Meyers BS, Teresi JA, Bruce ML, Ramirez M, Raue PJ, Perlick DA, Holmes D. The Cornell Service Index as a measure of health service use. Psychiatr Serv. 2005;56:1564–1569. doi: 10.1176/appi.ps.56.12.1564. [DOI] [PubMed] [Google Scholar]
  55. Browne GB, Arpin K, Corey P, Fitch M, Gafni A. Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care. 1990;28:43–58. doi: 10.1097/00005650-199001000-00006. [DOI] [PubMed] [Google Scholar]
  56. Forchuk C, Brown SA, Schofield R, Jensen E. Perceptions of health and health service utilization among homeless and housed psychiatric consumer/survivors. J Psychiatr Ment Health Nurs. 2008;15:399–407. doi: 10.1111/j.1365-2850.2007.01246.x. [DOI] [PubMed] [Google Scholar]
  57. Chisholm D. Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research: EPSILON Study 5. Br J Psychiatry. 2000;177:28s–33. doi: 10.1192/bjp.177.39.s28. [DOI] [PubMed] [Google Scholar]
  58. Tsemberis SJ, Moran L, Shinn M, Asmussen SM, Shern DL. Consumer preference programs for individuals who are homeless and have psychiatric disabilities: a drop-in center and a supported housing program. Am J Community Psychol. 2003;32:305–317. doi: 10.1023/b:ajcp.0000004750.66957.bf. [DOI] [PubMed] [Google Scholar]
  59. Toro PA, Passero Rabideau JM, Bellavia CW, Daeschler CV, Wall DD, Thomas DM, Smith SJ. Evaluating an intervention for homeless persons: results of a field experiment. J Consult Clin Psychol. 1997;65:476–484. doi: 10.1037//0022-006x.65.3.476. [DOI] [PubMed] [Google Scholar]
  60. Dickerson FB, Origoni AE, Pater A, Friedman BK, Kordonski WM. An expanded version of the Multnomah Community Ability Scale: anchors and interview probes for the assessment of adults with serious mental illness. Community Ment Health J. 2003;39:131–137. doi: 10.1023/A:1022610620391. [DOI] [PubMed] [Google Scholar]
  61. Sheehan DV, Lecrubier Y, Harnett Sheehan K, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12:232–241. doi: 10.1016/S0924-9338(97)83297-X. [DOI] [Google Scholar]
  62. Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, Janavs J, Dunbar GC. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12:224–231. doi: 10.1016/S0924-9338(97)83296-8. [DOI] [Google Scholar]
  63. Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry. 1998;13:26–34. doi: 10.1016/S0924-9338(97)86748-X. [DOI] [PubMed] [Google Scholar]
  64. Nasreddine ZSZ, Phillips NAN, Bédirian VV, Charbonneau SS, Whitehead VV, Collin II, Cummings JLJ, Chertkow HH. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x. [DOI] [PubMed] [Google Scholar]
  65. Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol. 1996;31:78–88. doi: 10.1007/BF00801903. [DOI] [PubMed] [Google Scholar]
  66. Uttaro T, Lehman A. Graded response modeling of the Quality of Life Interview. Eval Program Plann. 1999;22:41–52. doi: 10.1016/S0149-7189(98)00039-1. [DOI] [Google Scholar]
  67. Lancon CC, Auquier PP, Launois RR, Toumi MM, Llorca PMP, Bebbington PP, Lehman AA. [Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview] Encephale. 2000;26:11–16. [PubMed] [Google Scholar]
  68. Giffort D, Schmook A, Woody C, Vollendorf C, Gervain M. Construction of a Scale to Measure Consumer Recovery. Office of Mental Health: Springfield, IL; 1995. [Google Scholar]
  69. Corrigan PW, Giffort D, Rashid F, Leary M, Okeke I. Recovery as a psychological construct. Community Ment Health J. 1999;35:231–239. doi: 10.1023/A:1018741302682. [DOI] [PubMed] [Google Scholar]
  70. Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the recovery assessment scale. Schizophr Bull. 2004;30:1035–1041. doi: 10.1093/oxfordjournals.schbul.a007118. [DOI] [PubMed] [Google Scholar]
  71. Tsemberis S, McHugo G, Williams V, Hanrahan P, Stefancic A. Measuring homelessness and residential stability: The residential time-line follow-back inventory. Am J Community Psychol. 2007;35:29–42. doi: 10.1002/jcop.20132. [DOI] [Google Scholar]
  72. Ware JJ, Kosinski MM, Keller SDS. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233. doi: 10.1097/00005650-199603000-00003. [DOI] [PubMed] [Google Scholar]
  73. Larson CO. Use of the SF-12 instrument for measuring the health of homeless persons. Health Serv Res. 2002;37:733–750. doi: 10.1111/1475-6773.00046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93:1857–1867. doi: 10.1046/j.1360-0443.1998.9312185711.x. [DOI] [PubMed] [Google Scholar]
  75. Latimer J, Morton-Bourgon K, Chrétien JA. A Meta-Analytic Examination of Drug Treatment Courts: Do they Reduce Recidivism? Department of Justice Canada: Ottawa, ON; 2006. [Google Scholar]
  76. Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;36:223–233. [Google Scholar]
  77. Horvath AO, Greenberg LS. (Eds): The Working Alliance: Theory, Research, and Practice. Chichester: John Wiley & Sons; 1994. [Google Scholar]
  78. Tracey TJ, Kokotovic AM. Factor structure of the Working Alliance Inventory. Psychol Assess. 1989;1:207–210. [Google Scholar]
  79. Tichenor V, Hill CE. A comparison of six measures of working alliance. Psychother Theory Res Practice. 1989;26:195–199. [Google Scholar]
  80. Busseri MAM, Tyler JDJ. Interchangeability of the Working Alliance Inventory and Working Alliance Inventory, Short Form. Psychol Assess. 2003;15:193–197. doi: 10.1037/1040-3590.15.2.193. [DOI] [PubMed] [Google Scholar]
  81. City of Vancouver. Housing and Homelessness Strategy 2012–2021. Vancouver, BC: City of Vancouver; 2011. http://vancouver.ca/docs/policy/housing-council-presentation.PDF. [Google Scholar]
  82. Tsemberis SJ. Housing First: The Pathways Model to End Homelessness for People with Mental Illness and Addiction. Hazelden: Center City, MN; 2010. [Google Scholar]
  83. Schutt RK, Goldfinger SM. Housing preferences and perceptions of health and functioning among homeless mentally ill persons. Psychiatr Serv. 1996;47:381–386. doi: 10.1176/ps.47.4.381. [DOI] [PubMed] [Google Scholar]
  84. Schutt RK, Goldfinger SM. Research in Community and Mental Health, Volume 11. Emerald Group Publishing Limited: Morrissey JP. Bingley; 2000. The contingent rationality of housing preferences: Homeless mentally ill persons' housing choices before and after housing experience; pp. 131–156. [Google Scholar]
  85. Levitt AJ, Jost JJ, Mergl KA, Hannigan A, DeGenova J, Chung SY. Impact of chronically street homeless tenants in congregate supportive housing. Am J Orthopsychiatry. 2012;82:413–420. doi: 10.1111/j.1939-0025.2012.01164.x. [DOI] [PubMed] [Google Scholar]
  86. Kertesz SG, Crouch K, Milby JB, Cusimano RE, Schumacher JE. Housing first for homeless persons with active addiction: are we overreaching? Milbank Q. 2009;87:495–534. doi: 10.1111/j.1468-0009.2009.00565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES